Clinical trials
Medical Treatment clinical trials
Below are recruiting medical treatment clinical trials, each written for real people, not researchers. We’re tracking 1,130 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06918561Recruiting
NeoThelium FT for chronic open wounds
This trial tests a new skin-like graft called NeoThelium FT to see if it helps chronic open wounds heal faster. It is for adults with a non-infected wound that has been open for at least 4 weeks and is not a diabetic, pressure, or burn wound.
Denham Springs, LouisianaAges 18 years+ - NCT06279013Recruiting
Phone check-ins to manage symptoms during oral cancer treatment
This study tests two ways of using telephone check-ins to help people manage side effects and emotional distress while taking oral anti-cancer pills at home. If you are starting or recently started an oral anti-cancer drug, you may be able to join.
Phoenix, ArizonaAges 18 years+ - NCT05864053RecruitingPhase 1/Phase 2
Ketamine medicine trial for chronic nerve pain in adults
This Phase 1/2 study tests hydroxynorketamine (a related ketamine-type medicine) to see if it can reduce chronic nerve pain in the arms or legs. You may be able to join if you have nerve pain for more than 3 months and meet safety and health check requirements.
Chicago, IllinoisAges 18–75 - NCT03425669Recruiting
Using sound and balance exercises to help ADHD at school
This study tests whether adding specific sound and balance-related training at school can help children with ADHD. It may offer a non-medicine approach, and it also includes children without an ADHD diagnosis for comparison.
Lund, Skåne CountyAges 9–18 - NCT04153032RecruitingPhase 2
Two ointments for painful recent anal fissures
This Phase 2 trial compares MEBO ointment with diltiazem ointment to see which one heals an acute anal fissure (a small tear causing pain). You may be able to join if your fissure is recent and very painful, and you can pause other anal-area ointments during the study.
BeirutAges 18 years+ - NCT04678895RecruitingPhase 2
Low-dose naltrexone for nerve pain from diabetes
This Phase 2 trial studies whether a low dose of naltrexone can reduce painful nerve pain caused by diabetes. It may help people whose diabetic nerve pain did not improve with at least one standard treatment.
Lebanon, New HampshireAges 18 years+ - NCT05295615Recruiting
Pulsed magnetic treatment for mild to moderate Alzheimer’s
This trial tests whether a pulsed electromagnetic field (a non-drug device that uses magnetic pulses) can help people with mild to moderate Alzheimer’s. Participants typically stay on stable Alzheimer’s medicines and follow daily home treatments during the study.
Hackensack, New JerseyAges 50–100 - NCT05449548Recruiting
Lenalidomide for severe mouth ulcers from Behçet’s
This trial studies lenalidomide to treat frequent, ongoing mouth ulcers caused by mucosal Behçet’s syndrome. It’s meant for people whose mouth sores keep coming back despite standard treatments like steroid medicines and other immune-suppressing drugs.
Beijing, Beijing MunicipalityAges 18–65 - NCT05708352RecruitingPhase 2
Ketogenic diet vs usual diet guidance for newly diagnosed glioblastoma
This trial tests whether a very low-carb, high-fat ketogenic diet helps people with newly diagnosed glioblastoma when combined with standard cancer treatment. You would compare this special diet guidance to the usual anti-cancer diet guidance while receiving the same standard-of-care treatments.
Los Angeles, CaliforniaAges 18 years+ - NCT05799664Recruiting
Radiofrequency treatment for COPD using a breathing tube
This trial tests whether a special radiofrequency treatment delivered through a bronchoscope (a thin camera tube) is safe and works better than standard care for people with COPD. It focuses on people with moderate-to-severe COPD symptoms who can follow study visits and tests.
Chengdu, SichuanAges 40–75 - NCT06106191Recruiting
Mindfulness program for chronic low back pain
This trial tests a mindfulness-based program designed to help people with long-term low back pain. It aims to see if combining mindfulness with a personalized approach can improve pain management and daily functioning.
Boston, MassachusettsAges 18 years+ - NCT06244225RecruitingPhase 2
Triple therapy for advanced liver cancer (HAIC + sintilimab + donafenib)
This trial tests a combination of three treatments for advanced liver cancer that cannot be removed by surgery: a targeted oral drug (Donafenib), an immunotherapy (Sintilimab), and a type of chemotherapy given directly into the liver artery. The goal is to see if this triple therapy works better than current options for people who have not had any prior cancer treatment.
Wuhan, HubeiAges 18 years+ - NCT06272084Recruiting
Review of plasmapheresis treatments (TPE) using multiFiltratePRO
This study looks back at the medical records of people who had plasmapheresis (TPE) treatment to learn more about how it works. If you had this treatment between 2019 and 2023, researchers may use your data.
Aschaffenburg, BavariaAges 18 years+ - NCT06382675Recruiting
Testing a new plasma filter for blood cleaning treatment
This trial tests a new plasma filter, PX2, used in a procedure called therapeutic plasma exchange (TPE) to clean harmful substances from your blood. It’s for people who already need TPE and can safely use a blood thinner during the treatment.
Aschaffenburg, BavariaAges 18 years+ - NCT06454968RecruitingPhase 2
Combination therapy for first-line marginal zone lymphoma
This study tests a combination of three drugs—orelabrutinib, obinutuzumab, and lenalidomide—as a first treatment for marginal zone lymphoma. The goal is to see if this mix of targeted therapies works well and safely.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06520839RecruitingPhase 3
Tadalafil for erectile dysfunction in diabetic men
This trial studies whether a drug called tadalafil can help men with diabetes who also have erectile dysfunction. It looks at how genetic factors might affect treatment response.
LjubljanaAges 40–65 - NCT06791083RecruitingPhase 2
Envafolimab, Fruquintinib, and chemo before gastric cancer surgery
This trial tests a combination of two targeted drugs (Envafolimab and Fruquintinib) plus chemotherapy given before surgery for certain types of stomach cancer. The goal is to see if this approach can shrink the tumor and improve outcomes.
Fuzhou, FujianAges 18–75 - NCT06910306Recruiting
DaRT alpha radiation for recurrent glioblastoma
This trial tests a device called DaRT that delivers alpha radiation directly to a recurrent glioblastoma tumor. It may help patients who cannot have surgery and have a single, small tumor regrowth.
Scottsdale, ArizonaAges 18–85 - NCT07058883Recruiting
Study of Juläine Gel for Facial Acne Scars
This study is testing an investigational gel called Juläine to see if it can safely and effectively improve depressed acne scars on the face. If you have moderate to severe atrophic facial scars and haven't had other facial treatments recently, you may be a good candidate.
GdanskAges 18 years+ - NCT07109765Recruiting
Secukinumab for moderate to severe hidradenitis suppurativa
This study tests a drug called secukinumab (a type of biologic that targets inflammation) for people with moderate to severe hidradenitis suppurativa (HS). It may be an option if you have tried other treatments and they didn't work well.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07347860RecruitingEarly Phase 1
Study of A-319 for active rheumatoid arthritis
This trial tests a new drug called A-319 for people with active rheumatoid arthritis (RA) that hasn't improved enough after trying other treatments. The goal is to see if A-319 can reduce joint pain, swelling, and inflammation.
Wuhan, HubeiAges 18–70 - NCT07530705RecruitingPhase 1/Phase 2
XH-02 Injection for Low Parathyroid Hormone Levels
This study tests whether a new injectable medicine called XH-02 can safely treat hypoparathyroidism—a condition where your body doesn't make enough parathyroid hormone, causing low calcium levels. If your calcium isn't well-controlled with current treatments (calcium and vitamin D supplements), this trial might help.
Beijing, Beijing MunicipalityAges 18–65 - NCT07547735RecruitingPhase 2
Stem Cell Treatment for Knee Osteoarthritis
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
WuhanAges 40–70 - NCT07400510Enrolling by invitation
Ultrasound for DVT diagnosis and treatment
This trial uses a bedside ultrasound to quickly diagnose deep vein thrombosis (DVT) and help guide treatment. It may help patients who have symptoms like leg swelling or pain.
Hershey, PennsylvaniaAges 18 years+
Hear when a new Medical Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for medical treatment?
- Yes. Clin2 currently lists 1,130 recruiting medical treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a medical treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a medical treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.